XML 34 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation
12 Months Ended
Sep. 30, 2017
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation

NOTE 8. STOCK-BASED COMPENSATION

Arrowhead has two plans that provide for equity-based compensation. Under the 2004 Equity Incentive Plan and 2013 Incentive Plan, as of September 30, 2017, 2,119,286 and 6,329,079 shares, respectively, of Arrowhead’s Common Stock are reserved for the grant of stock options, stock appreciation rights, restricted stock awards and performance unit/share award to employees, consultants and others. No further grants may be made under the 2004 Equity Incentive Plan.  As of September 30, 2017, there were options granted and outstanding to purchase 2,119,286 and 2,986,207 shares of Common Stock under the 2004 Equity Incentive Plan and the 2013 Incentive Plan, respectively, and there were 3,098,000 restricted stock units granted and outstanding under the 2013 Incentive Plan. Also, as of September 30, 2017, there were 444,050 shares reserved for options and 10,000 restricted stock units issued as inducement grants to new employees outside of equity compensation plans. During the year ended September 30, 2017, no options or restricted stock units were granted under the 2004 Equity Incentive Plan, 591,000 options and 2,623,000 restricted stock units were granted under the 2013 Incentive Plan, and 47,000 options and 0 restricted stock units were granted as inducement awards to new employees outside of equity incentive plans.  

The following table summarizes information about stock options:

 

 

Number of
Options
Outstanding

 

 

Weighted-
Average
Exercise
Price
Per Share

 

  

Weighted-
Average
Remaining
Contractual
Term

 

  

Aggregate
Intrinsic
Value

 

Balance At September 30, 2016

 

6,691,200

  

 

$

6.56

  

  

 

 

 

 

 

 

 

Granted

 

638,000

 

 

 

1.95

  

  

 

 

 

 

 

 

 

Cancelled

 

(1,643,927)

 

 

 

7.02

  

  

 

 

 

 

 

 

 

Exercised

 

(135,730)

 

 

 

2.01

  

  

 

 

 

 

 

 

 

Balance At September 30, 2017

 

5,549,543

  

 

$

6.00

  

  

 

6.5 years

 

 

$

3,390,029

 

Exercisable At September 30, 2017

 

4,065,611

 

 

$

6.32

 

 

 

5.8 years

 

 

$

1,872,018

 

Stock-based compensation expense related to stock options for the years ended September 30, 2017, 2016 and 2015 was $4,524,833, $6,361,396, and $4,760,831, respectively. The Company does not recognize an income tax benefit as the Company is currently operating at a loss and an actual income tax benefit may not be realized. For non-qualified stock options, the loss creates a timing difference, resulting in a deferred tax asset, which is fully reserved by a valuation allowance.

The grant date fair value of the options granted by the Company for the years ended September 30, 2017, 2016 and 2015 was estimated at $849,816, $6,426,207 and $7,338,395, respectively.

The intrinsic value of the options exercised during the years ended September 30, 2017, 2016 and 2015 was $35,512, $142,690 and $128,391, respectively.

As of September 30, 2017, the pre-tax compensation expense for all outstanding unvested stock options in the amount of approximately $4,627,267 will be recognized in the Company’s results of operations over a weighted average period of 1.8 years.

The fair value of each stock option award is estimated on the date of grant using the Black-Scholes option pricing model. The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options, which do not have vesting restrictions and are fully transferable. The determination of the fair value of each stock option is affected by the Company’s stock price on the date of grant, as well as assumptions regarding a number of highly complex and subjective variables. Because the Company’s employee stock options have characteristics significantly different from those of traded options, and because changes in the subjective input assumptions can materially affect the fair value estimate, in management’s opinion, the existing models do not necessarily provide a reliable single measure of the fair value of its employee stock options.

The assumptions used to value stock options are as follows:

 

 

 

 

Years ended September 30,

 

 

2017

 

2016

 

2015

Dividend yield

 

 

 

Risk-free interest rate

 

1.34 – 2.31%

 

1.05 – 1.89%

 

1.46 – 1.89%

Volatility

 

79%

 

89%

 

75%

Expected life (in years)

 

5.85

 

6.25

 

6 - 6.25

Weighted average grant date fair value per share of options granted

 

$1.33

 

$4.58

 

$4.24

The dividend yield is zero as the Company currently does not pay a dividend.

The risk-free interest rate is based on that of the U.S. Treasury bond.

Volatility is estimated based on volatility average of the Company’s Common Stock price.

Restricted Stock Units

Restricted stock units (RSUs), including time-based and performance-based awards, were granted under the Company’s 2013 Incentive Plan and as inducement grants granted outside of the Plan.  During the year ended September 30, 2017, the Company awarded 2,623,000 restricted stock units to certain members of management.  Of the restricted stock units granted during the year ended September 30, 2017, 0 were granted outside of the Plan as an inducement grant to a new employee. At vesting, each RSU will be exchanged for one share of the Company’s Common Stock. Restricted stock unit awards generally vest subject to the satisfaction of service requirements or the satisfaction of both service requirements and achievement of certain performance targets.  

The following table summarizes the activity of the Company’s Restricted Stock Units:

 

 

Number of
RSUs

 

 

Weighted-
Average
Grant
Date
Fair Value

 

Unvested at September 30, 2016

 

1,356,667

 

 

$

6.72

 

Granted

 

2,623,000

 

 

 

1.59

 

Vested

 

(786,667

 

 

7.03

 

Forfeited

 

(85,000

 

 

1.55

 

Unvested at September 30, 2017

 

3,108,000

 

 

$

2.45

 

During the years ended September 30, 2017, 2016 and 2015, the Company recorded $3,366,762, $5,234,420 and $4,489,931 of expense related to restricted stock units, respectively. Such expense is included in stock-based compensation expense in the Company’s Consolidated Statement of Operations and Comprehensive Loss.  

For restricted stock units, the grant date fair value of the award is based on the Company’s closing stock price at the grant date.  Expense is recognized over the vesting period for all awards, and commences at the grant date for time-based awards and upon the Company’s determination that the achievement of such performance conditions is probable for performance-based awards.

As of September 30, 2017, the pre-tax compensation expense for all unvested restricted stock units in the amount of approximately $2,448,449 will be recognized in the Company’s results of operations over a weighted average period of 1.1 years.